NASDAQ:BMEA • US09077A1060
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOMEA FUSION INC (BMEA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-13 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-10 | Citigroup | Maintains | Buy -> Buy |
| 2025-11-05 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-10-27 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-10-07 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-10-03 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-28 | Jefferies | Initiate | Buy |
| 2025-08-11 | Citigroup | Maintains | Buy -> Buy |
| 2025-08-06 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-06 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-07-21 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-07-16 | Citigroup | Maintains | Buy -> Buy |
| 2025-06-24 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-18 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-13 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-15 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-06 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-04-02 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-24 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-19 | D. Boral Capital | Maintains | Buy -> Buy |
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A 104.46% | N/A 176.78% | N/A 104.40% | |||||||
| EBITDA YoY % growth | -1.2M | -5.32M -343.33% | -41.42M -678.57% | -82.94M -100.24% | -124.62M -50.25% | -142.322M -14.20% | N/A 36.22% | N/A -5.77% | N/A -17.11% | N/A -29.00% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -1.2M | -5.33M -344.17% | -41.67M -681.80% | -83.63M -100.70% | -126.135M -50.83% | -144.07M -14.22% | N/A 37.37% | N/A -3.80% | N/A -21.11% | N/A -16.90% | N/A -5.77% | N/A 65.26% | N/A 178.41% | N/A 896.36% | N/A 158.85% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -1.76 | -2.79 -58.52% | -3.46 -24.01% | -3.84 -10.98% | N/A 59.33% | N/A 30.23% | N/A -26.67% | N/A 19.46% | N/A 11.93% | N/A 89.58% | N/A 1,500.00% | N/A 210.00% | N/A 108.76% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.26 68.33% | -0.25 68.55% | -0.23 55.33% | -0.23 13.11% | -0.25 1.92% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -18.683M 34.04% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -16.958M 43.61% | -23.868M 19.67% | -17.85M 16.10% | -18.36M 1.29% | -19.38M -14.28% |
All data in USD
13 analysts have analysed BMEA and the average price target is 7.14 USD. This implies a price increase of 561.11% is expected in the next year compared to the current price of 1.08.
BIOMEA FUSION INC (BMEA) will report earnings on 2026-04-06, after the market close.
The consensus EPS estimate for the next earnings of BIOMEA FUSION INC (BMEA) is -0.26 USD and the consensus revenue estimate is 0 USD.
The consensus rating for BIOMEA FUSION INC (BMEA) is 83.0769 / 100 . This indicates that analysts generally have a positive outlook on the stock.